Ionis to present at 42nd Annual J.P. Morgan Healthcare Conference
CARLSBAD, Calif., Dec. 20, 2023 /PRNewswire/ — Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that Brett P. Monia, Ph.D., chief executive officer, will present a company overview at the 42nd Annual J.P. Morgan Healthcare Conference at 3:00 p.m. PT on Wednesday, January 10, 2024.
Related news for (IONS)
- Midday Movers: Biotech Breakouts, Special Payouts, and Strategic Power Plays
- Eplontersen granted U.S. FDA Fast Track designation for patients with transthyretin-mediated amyloid cardiomyopathy
- Ionis to hold fourth quarter and full year 2023 financial results webcast
- Ionis poised for continued momentum in 2024 with product launches and key advances in robust pipeline of investigational medicines for serious diseases
- WAINUA™ (eplontersen) granted regulatory approval in the U.S. for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated amyloidosis